Sevoflurane Acts on Ubiquitination–Proteasome Pathway to Reduce Postsynaptic Density 95 Protein Levels in Young Mice. (December 2017)

• Record Type: Journal Article
• Authors: Lu, Han; Liufu, Ning; Dong, Yuanlin; Xu, Guanghong; Zhang, Yiying; Shu, Liqi; Soriano, Sulpicio G.; Zheng, Hui; Yu, Buwei; Xie, Zhongcong
• Is Part Of: Anesthesiology. Volume 127:Number 6(2017)
• Publication Date: 2017-12
• Subjects: Anesthesiology -- Periodicals; Anesthetics -- Periodicals; Anesthesia -- Periodicals; 617.9605
• DOI: 10.1097/ALN.0000000000001889
• Languages: English
• ISSNs: 0003-3022

Abstract

Abstract : Background: Children with multiple exposures to anesthesia and surgery may have an increased risk of developing cognitive impairment. Sevoflurane, a commonly used anesthetic in children, has been reported to decrease levels of postsynaptic density 95 protein. However, the upstream mechanisms and downstream consequences of the sevoflurane-induced reduction in postsynaptic density 95 protein levels remains largely unknown. We therefore set out to assess whether sevoflurane acts on ubiquitination–proteasome pathway to facilitate postsynaptic density 95 protein degradation. Methods: Six-day-old wild-type mice received anesthesia with 3% sevoflurane 2 h daily for 3 days starting on postnatal day 6. We determined the effects of the sevoflurane anesthesia on mRNA, protein and ubiquitinated levels of postsynaptic density 95 protein in neurons, and synaptosomes and hippocampus of young mice. Cognitive function in the mice was determined at postnatal day 31 by using a Morris water maze. Proteasome inhibitor MG132 and E3 ligase mouse double mutant 2 homolog inhibitor Nutlin-3 were used for the interaction studies. Results: The sevoflurane anesthesia decreased protein, but not mRNA, levels of postsynaptic density 95, and reduced ubiquitinated postsynaptic density 95 protein levels in neurons, synaptosomes, and hippocampus of young mice. Both MG132 and Nutlin-3 blocked these sevoflurane-induced effects. Sevoflurane promoted the interaction of mouse double mutant 2 homolog and postsynaptic density 95 protein in neurons. Finally, MG132 and Nutlin-3 ameliorated the sevoflurane-induced cognitive impairment in the mice. Conclusions: These data suggest that sevoflurane acts on the ubiquitination–proteasome pathway to facilitate postsynaptic density 95 protein degradation, which then decreases postsynaptic density 95 protein levels, leading to cognitive impairment in young mice. These studies would further promote the mechanistic investigation of anesthesia neurotoxicity in the developing brain. Abstract : Multiple sevoflurane exposures reduced postsynaptic density 95 protein (PSD-95) levels by increasing ubiquitination and proteosomal degradation; inhibition of the ubiquitin–proteosome pathway prevented PSD-95 loss and mitigated cognitive dysfunction. The results are consistent with the notion that anesthetic neurotoxicity may result, in part, by reducing PSD-95 levels decreasing neuroplasticity.Supplemental Digital Content is available in the text.